Charles Schwab’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.09M | Buy |
745,071
+90,940
| +14% | +$866K | ﹤0.01% | 2172 |
|
|
2025
Q1 | $6.84M | Sell |
654,131
-13,321
| -2% | -$139K | ﹤0.01% | 2140 |
|
|
2024
Q4 | $15.7M | Buy |
667,452
+18,800
| +3% | +$443K | ﹤0.01% | 1818 |
|
|
2024
Q3 | $23.3M | Buy |
648,652
+47,590
| +8% | +$1.71M | ﹤0.01% | 1615 |
|
|
2024
Q2 | $21.2M | Buy |
601,062
+139,540
| +30% | +$4.92M | ﹤0.01% | 1644 |
|
|
2024
Q1 | $13.1M | Buy |
461,522
+129,954
| +39% | +$3.69M | ﹤0.01% | 1842 |
|
|
2023
Q4 | $4.41M | Buy |
331,568
+6,197
| +2% | +$82.4K | ﹤0.01% | 2366 |
|
|
2023
Q3 | $2.92M | Buy |
325,371
+40,250
| +14% | +$361K | ﹤0.01% | 2477 |
|
|
2023
Q2 | $3.21M | Buy |
285,121
+57,537
| +25% | +$647K | ﹤0.01% | 2398 |
|
|
2023
Q1 | $2.62M | Sell |
227,584
-558
| -0.2% | -$6.43K | ﹤0.01% | 2449 |
|
|
2022
Q4 | $2.64M | Buy |
228,142
+5,708
| +3% | +$66.2K | ﹤0.01% | 2475 |
|
|
2022
Q3 | $2.83M | Buy |
222,434
+43,281
| +24% | +$550K | ﹤0.01% | 2477 |
|
|
2022
Q2 | $1.23M | Sell |
179,153
-13,324
| -7% | -$91.6K | ﹤0.01% | 2716 |
|
|
2022
Q1 | $1.86M | Buy |
192,477
+3,918
| +2% | +$37.8K | ﹤0.01% | 2669 |
|
|
2021
Q4 | $2.24M | Buy |
188,559
+4,376
| +2% | +$52K | ﹤0.01% | 2667 |
|
|
2021
Q3 | $2.99M | Buy |
184,183
+32,557
| +21% | +$529K | ﹤0.01% | 2600 |
|
|
2021
Q2 | $3.19M | Buy |
151,626
+29,134
| +24% | +$613K | ﹤0.01% | 2563 |
|
|
2021
Q1 | $1.9M | Buy |
122,492
+40,216
| +49% | +$625K | ﹤0.01% | 2678 |
|
|
2020
Q4 | $1.73M | Buy |
+82,276
| New | +$1.73M | ﹤0.01% | 2628 |
|